Registration No. 333 - *****
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REGISTRATION STATEMENT
ON FORM S-3
UNDER
THE SECURITIES ACT OF 1933
MARK SOLUTIONS, INC.
(Exact Name of Registrant as Specified in Charter)
Delaware 11-2864481
(State of (I.R.S. Employer
Incorporation) Identification
Number)
1515 Broad Street Parkway Technical Center
Bloomfield, New Jersey 07003
(201)893-0500
(Address, including Zip Code and Telephone Number
of Registrant's Principal Executive Offices)
Carl Coppola, President
Mark Solutions, Inc.
1515 Broad Street
Bloomfield, New Jersey 07003
(201) 893-0500
(Name, Address, including Zip Code, and Telephone Number of Agent for Service)
A copy to:
Timothy J. McCartney, Esq.
9 Elsa Way
Richboro, Pennsylvania 18954
(215) 396-7156
Approximate date of proposed sale to the public:
As soon as practicable after the effective date of this Registration
Statement.
If the only securities being registered on this form are being offered pursuant
to dividend or reinvestment plans, please check the following box: [ ]
If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box: [XX]
If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act Registration Statement number of the earlier effective
registration statement for the same offering. [ ] .
[COVER PAGE 1 OF 2 PAGES]
<PAGE>
If this Form is a post effective amendment filed pursuant to Rule 462(c) under
the Securities Act, please check the following box and list the Securities Act
registration Statement number of the earlier effective registration statement
for the same offering. [ ] . If delivery of the prospectus is expected to be
made pursuant to Rule 434, please check the following box [ ].
<TABLE>
<CAPTION>
CALCULATION OF REGISTRATION FEE
=====================================================================================================
Title of Each Amount to be Proposed Maximum Proposed Maximum Amount of
Class of Securities Registered(1) Offering Price Aggregate of Registration Fee (1)
to be Registered Per Share (2) Offering Price (2)
- -----------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Common Stock,
$.01 par value 10,000,000 $ 0.75 $7,500,000 $ 2,272.50
=====================================================================================================
<FN>
(1) Also registered hereby pursuant to Rule 416 are such additional
indeterminate shares of Common Stock or other securities as may become issuable
by reason of stock splits or other adjustments pursuant to antidilution
provisions.
(2) Estimated solely for purposes of calculating registration fee
pursuant to Rule 457(c) based upon the last sales price as reported on Nasdaq
within the prior five days.
</FN>
</TABLE>
The Registrant hereby amends this Registration Statement on such date or dates
as may be necessary to delay its effective date until the Registrant shall file
a further amendment which specifically states that this Registration Statement
shall thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.
[COVER PAGE 2 OF 2 PAGES]
<PAGE>
Prospectus
MARK SOLUTIONS, INC.
10,000,000 Shares of Common Stock
This Prospectus relates to the sale of up to 10,000,000 shares of common
stock, $.01 par value (the "Common Stock") of Mark Solutions, Inc. ("Mark")
consisting of (i) 1,220,000 issued shares of Common Stock (the "Private
Placement Common Stock"), (ii) 1,375,000 shares of Common Stock which are
issuable upon the exercise of warrants at $ 1.50 per share (the "Warrants"),
(iii) an indeterminate number of shares of Common Stock which are issuable upon
conversion of Mark's $1,530,000 Principal Amount 7% Convertible Debentures due
December 28, 2000 (the "Debentures"), (iv) an indeterminate number of shares of
Common Stock issuable pursuant to certain adjustments on the Private Placement
Common Stock (the "Adjustment Shares") and (v) an indeterminate number of shares
of Common Stock issuable to pay interest on the Debentures (the "Interest
Shares"). The Private Placement Common Stock, Warrants, Debentures, Adjustment
Shares and Interest Shares are collectively referred to as the "Securities". The
Securities were issued by Mark in a private placement in June 1998. See
"Description of Securities" for the terms of the Securities.
Mark is obligated to keep the registration statement (the "Registration
Statement"), of which this Prospectus forms a part, effective until June 29,
2000.
All of the shares of Common Stock offered hereby (the "Shares") are being
sold for the account of and by the person(s) named under the caption "Selling
Shareholders". Mark is bearing the cost related to the Registration Statement.
The Selling Shareholders have advised Mark that the Shares may be sold by the
Selling Shareholders or its pledgees, donees, transferees or other successors in
interest from time to time in the open market or in privately negotiated
transactions at prices satisfactory to the seller. See "Plan of Distribution".
Mark will receive no proceeds from the sale of the Shares.
THESE SECURITIES INVOLVE A HIGH DEGREE OF RISK. See "Risk Factors".
The Common Stock is traded on the Nasdaq SmallCap Market under the symbol
"MCSI". On August **, 1998, the closing sales price of the Common Stock was $
*-*/* per share.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND
EXCHANGE COMMISSION OR BY ANY STATE SECURITIES COMMISSION NOR HAS THE SECURITIES
AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION PASSED UPON THE
ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
-------------------------------------------
The date of this Prospectus is August **, 1998.
1
<PAGE>
No person is authorized to give any information or to make any representations
other than those contained in this Prospectus, and, if given or made, such
information or representations should not be relied upon as having been
authorized. This Prospectus does not constitute an offer to sell, or
solicitation of an offer to purchase, the securities offered by this Prospectus,
in any jurisdiction to or from any person to whom or from whom it is unlawful to
make such offer or solicitation of an offer in such jurisdiction. Neither the
delivery of this Prospectus nor any distribution of the securities being offered
pursuant to this Prospectus shall, under any circumstances, create an
implication that there has been no change in the information set forth herein
since the date of this Prospectus.
TABLE OF CONTENTS
Page
Available Information . . . . . . . . . . . . . . . . . . 2
Incorporation of Certain Documents by Reference . . . . . 3
The Company . . . . . . . . . . . . . . . . . . . . . . . 4
Summary Selected Financial Data . . . . . . . . . . . . . 5
Risk Factors. . . . . . . . . . . . . . . . . . . . . . . 6
Description of Securities . . . . . . . . . . . . . . . . 10
Selling Shareholders . . . . . . . . . . . . . . . . . . 11
Plan of Distribution . . . . . . . . . . . . . . . . . . 12
Legal Matters . . . . . . . . . . . . . . . . . . . . . . 13
Experts . . . . . . . . . . . . . . . . . . . . . . . . . 13
AVAILABLE INFORMATION
Mark has filed with the Commission a Registration Statement on Form S-3
(together with all amendments and exhibits thereto the "Registration Statement")
under the Securities Act with respect to the Common Stock offered hereby. As
permitted by the rules and regulations of the Commission, this Prospectus omits
certain information contained in the Registration Statement. For such
information, reference is made to the Registration Statement and the exhibits
thereto. Mark is subject to the informational requirements of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance
therewith Mark files reports and other information with the Commission.
The Registration Statement, reports and other information filed by Mark
with the Commission can be inspected and copied at the public reference
facilities maintained by the Commission at Room 1024, 450 Fifth Street, N.W.,
Washington, D.C. 20549, and at the Commission's Regional Offices at 7 World
Trade Center, Suite 1300, New York, New York 10048, 1401 Brickell Avenue, Suite
200, Miami, Florida 33131, 500 West Madison Street, Suite 1400, Chicago,
Illinois 60661, 1801 California Street, Suite 4800, Denver, Colorado 80202 and
5670 Wilshire Boulevard, 11th Floor, Los Angeles, California 90036. Copies of
such material also can be obtained from the Public Reference Section of the
Commission, Washington, D.C. 20549 at prescribed rates. In addition, the
Commission maintains an internet site (http:// www.sec.gov) that contains
reports, proxy statements and other information regarding Mark, which is an
electronic filer under Regulation S-T.
2
<PAGE>
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents previously filed by Mark (Commission File No.
0-17118) with the Commission pursuant to the Exchange Act are incorporated and
made a part of this Prospectus by reference:
(1) Mark's Annual Report on Form 10-K for the year ended June 30, 1997;
(2) Mark's Quarterly Report on Form 10-Q for the period ended September 30,
1997;
(3) Mark's Quarterly Report on Form 10-Q for the period ended December 31, 1997,
as amended;
(4) Mark's Quarterly Report on Form 10-Q for the period ended March 31, 1998;
(5) Mark's Current Report on Form 8-K dated April 15, 1998;
(6) Mark's Current Report on Form 8-K dated June 29,1998;
(7) The description of the Common Stock contained in the registration Statement
on Form 8-A.
All documents filed by Mark pursuant to Section 13(a), 13(c), 14 or 15(d)
of the Exchange Act subsequent to the date of this Prospectus and prior to the
termination of the offering contemplated by his Prospectus shall be deemed to be
incorporated by reference into this Prospectus and to be a part hereof from the
date of filing such documents. Any statements contained herein or in a document
incorporated or deemed to be incorporated by reference herein shall be deemed to
be modified or superseded for purposes of this Prospectus to the extent that a
statement contained herein or in any subsequently filed documents which also is
or is deemed to be incorporated by reference herein modified or supersedes such
earlier statement. Any statement so modified or superseded shall not be deemed,
except as so modified or superseded, to constitute a part of this Prospectus.
Mark undertakes to provide without charge to each person, including any
beneficial owner, to whom a copy of this Prospectus has been delivered, on
written or oral request of any such person, a copy of any or all of the
documents referred to above which have been or may be incorporated by reference
in the Prospectus, other than exhibits to such documents (unless such documents
are specifically incorporated by reference in such documents). Requests for such
copies should be directed to Ms. Cheryl Gomes, Mark Solutions, Inc., 1515 Broad
Street, Bloomfield, New Jersey 07003, Telephone Number (201) 893-0500.
3
<PAGE>
THE COMPANY
Mark Solutions, Inc. ("Mark") is a Delaware corporation which operates its
businesses through wholly-owned subsidiaries and a division.
Mark is engaged in the design, manufacture and/or installation of (i)
modular steel cells for correctional institution construction and (ii)
diagnostic support, picture, archiving and communication computer systems (PACS)
marketed under the name "IntraScan".
Modular Steel Cells. Mark markets its modular steel products by responding
to public bids and by pursuing joint ventures and affiliations with other
companies to solicit design, build and/or operate correctional facilities
projects both domestically and internationally. Management believes that
nationwide emphasis on expedient easing of overcrowding conditions in
correctional institutions presents a significant growth opportunity; however,
there can be no assurance of sustained business.
Mark's modular cells can be manufactured and installed more efficiently
than traditional housing alternatives by virtue of lower labor and construction
costs and shorter installation time.
IntraScan PACS System. Mark markets its IntraScan PACS systems to radiology
departments, large healthcare facilities, hospitals and outpatient imaging group
practices, primarily through a marketing agreement with Data General
Corporation. Management believes that it can capitalize on the development of
the domestic and international PACS market; however, there can be no assurance
that significant business will develop.
The IntraScan PACS system interfaces with medical imaging devices to store
and recall images digitally from modalities including x-ray, CAT Scan, MRI,
ultrasound, computed radiography and nuclear medicine. The IntraScan PACs system
is "platform independent" allowing the software to operate with most computer
hardware and operating systems.
Mark was incorporated under the laws of the State of Delaware on September
29, 1986 under the name "Showcase Cosmetics, Inc." Mark's principal executive
office is located at Parkway Technical Center, 1515 Broad Street, Bloomfield,
New Jersey 07003 and its telephone number is (201) 893-0500.
4
<PAGE>
SUMMARY SELECTED FINANCIAL DATA
The following summary selected financial data is based upon financial
information incorporated herein and such summary information should be read in
conjunction with such financial statements and notes thereto.
Income Statement Data:
<TABLE>
<CAPTION>
Nine Months Ended
March 31 Fiscal Years Ended June 30
----------------------- ------------------------------------------------
1998 1997 1997 1996 1995
----------------------- ------------------------------------------------
<S> <C> <C> <C> <C> <C>
Revenue ................ $ 12,719,161 $ 3,276,578 $ 6,449,744 $ 3,454,615 $ 6,125,573
Cost and Expenses ...... 12,206,393 5,564,803 10,191,950 8,518,483 9,852,303
Operating Income (Loss) 512,768 (2,288,225 (3,742,206) (5,063,868) (3,726,730)
Net Other (Expenses) ... (404,909) (710,576) (1,697,059) (46,691) (85,905)
Net Income (Loss) From
Continuing Operations 107,859 (2,998,801) (5,439,265) (5,110,559) (3,812,635)
(Loss) From Discontinued
Operations ............ - - - - - - - - - (104,503) (1,337,438)
Net Income (Loss) ...... 107,859 (2,998,801) (5,439,265) (5,215,062) (5,190,073)
Earnings (Loss) per
Share .................. $ .01 ($ .21) ($ .38) ($ .41 ($ .48)
Weighted Average
Shares Outstanding .... 16,310,982 13,974,665 14,221,606 12,732,022 10,726,204
</TABLE>
Balance Sheet Data:
<TABLE>
<CAPTION>
At March 31 At June 30
----------- ----------
1998 1997 1996 1995
--------- -------------------------------------------
<S> <C> <C> <C> <C>
Working Capital (Deficit) $ 2,735,227 $ 923,457 $ 675,864 ( $48,112)
Total Assets ............ 5,956,570 5,432,277 3,083,763 3,978,383
Long-term Obligations ... 1,085,024 2,340,467 50,297 19,665
Total Liabilities ....... 3,057,136 5,585,430 1,004,362 2,189,322
Stockholders' Equity
(Impairment) .......... 2,899,434 (153,153) 2,079,061 1,789,061
</TABLE>
5
<PAGE>
RISK FACTORS
Prospective investors in the Common Stock should give careful consideration
to the following risks in making a decision concerning the securities offered
hereby.
1. Poor Financial Condition. Mark has experienced significant operating
losses and working capital and liquidity deficiencies over the past several
years. Mark had net losses of $5,439,265 and $5,215,062 for the fiscal years
ended June 30, 1997 and 1996. In addition, Mark had an accumulated deficit of
$27,755,925 at June 30, 1997. Mark has and will continue to experience such
financial difficulties in the foreseeable future absent significant increases in
the sale of modular cells and/or IntraScan PACS systems. Accordingly, based on
past operating results there can be no assurance that Mark will be able to
operate profitably. Mark's poor financial condition could adversely effect its
ability to raise additional working capital pursuant to private sales of its
securities.
2. Limited Market; Contracts for Modular Cells. Mark has derived
substantially all of its revenue from the sale of its modular cells to
correctional institutions and management believes that the sale of these
products will continue to represent the substantial majority of Mark's operating
revenues through December 31, 1998. The correctional institution market presents
substantial sales obstacles. Unless the project is very small, correctional
institutions, like other government agencies, must submit proposed projects to
public bidding by prospective suppliers. The purchasing agency is obligated to
select from among the bidders based on objective criteria. On the other hand,
private purchasers generally do not require bidding and a vendor such as Mark
would have the opportunity to convince the purchaser to deal with Mark to the
exclusion of competitors.
Mark continually bids on and solicits joint venture opportunities regarding
construction projects utilizing its modular steel cell products. At present,
Mark is not participating in any projects under a joint venture format. Mark
currently has contracts for it modular cells aggregating approximately
$2,500,000 in revenue for the period beginning July 1, 1998 to October 31, 1998.
3. Limited Sales of IntraScan PACS Systems. For the three fiscal years
ended June 30, 1998, Mark's revenues from the sale of IntraScan PACS systems and
related products totalled $474,373. While Mark believes the domestic and
international market for PACS systems is significant and expanding, there can be
no assurance that Mark will establish a material market share and run its
IntraScan operations profitably.
6
<PAGE>
4. Working Capital Requirements. The ultimate success of
Mark may depend upon its ability to raise additional equity or obtain debt
financing until it can improve its operating results. To date Mark has primarily
met its working capital requirements by the private issuance of its securities,
including the Securities. Absent proceeds from the exercise of outstanding
warrants and improvement in the operations of Mark, management believes that its
present available working capital will be utilized by December 31, 1999. In the
event Mark must seek other sources of working capital, it will most likely have
to rely on additional private sales of its equity or debt securities. While Mark
has been successful in raising working capital through private sources in the
past, no assurance can be given that such sources will be available, or, if
available, on terms satisfactory to Mark. Mark will initially look to the
exercise of outstanding warrants to the extent that additional working capital
is necessary.
5. Significant Contract. For the fiscal year ended June 30, 1998,
$12,000,000 (93.0%) of Mark's revenue was attributable to its contract to
provide modular cells to the State of New York. The agreement has a stated
estimate of 2,455 cells over the three-year term ending December 31, 1999,
however, no minimum volume is guaranteed. In addition, the State of New York
reserves the right to renegotiate the stated contract prices or solicit third
party bids for any single order of 700 or more cells. Accordingly, no assurances
can be given that Mark will receive additional significant orders under this
agreement.
6. Competition. Mark competes in two industries which are highly
competitive; government construction and computer software.
Due to the use of concrete and other traditional construction methods in
the substantial majority (approximately 90%) of correctional facilities
construction, Mark competes for market share with a number of major national and
regional construction companies in its efforts to convince the purchasing agency
to utilize steel cell construction rather than traditional methods. With respect
to those projects which incorporate modular steel cell in its design criteria,
Mark competes against other regional metal fabricators, some of which have
greater financial resources than Mark. In addition, other sheet metal
manufacturers which have greater financial and marketing resources than Mark
could enter the modular cell business. Accordingly, there can be no assurance
that Mark will be able to successfully compete in the market for modular steel
cells.
With regard to the IntraScan PACS system, other companies, including
several established film and medical equipment manufacturers, which are larger
and better financed than Mark, offer PACS systems. As the PACS market develops
other large medical equipment, computer hardware or software companies could
enter the PACS business. Accordingly, there can be no assurance that Mark will
be able to successfully compete in the PACS market.
7
<PAGE>
7. Dependence on Key Person. Mark is dependent upon the continued services
of Carl Coppola, its Chairman of the Board, President and Chief Executive
Officer. The loss of Mr. Coppola could have a material adverse effect on Mark.
Mark is the beneficiary of a term life insurance policy of $1,000,000 on the
life of Mr. Coppola.
8. Bonding Qualifications. In connection with some government construction
projects, Mark is required to provide performance and completion bonds as a
condition to submission or participation in a bid. Due to Mark's financial
condition, it has generally been unable to obtain bonds without the assistance
and guarantee of third parties, including Mark's president and/or another
business entity owned by an outside director. To date Mark has not limited its
bidding activity nor lost any projects due to its limited bonding capacity.
However, as Mark is awarded multiple projects, the inability to obtain bonds may
limit the number of additional projects Mark can pursue and have a material
adverse effect on the operations of Mark.
9. Recent Trading Prices; Nasdaq Listing Maintenance Requirements. Since
August 4, 1998, Mark's Common Stock has traded below $1.00 per share. Mark's
Common Stock trades on the Nasdaq SmallCap Market. To be eligible for continued
listing of its Common Stock, Mark is required to maintain, among other things,
(i) a minimum bid price of $1.00 per share and (ii) minimum net tangible assets
of $2,000,000 or a market capitalization of $35 million. If Mark fails to
maintain its Nasdaq SmallCap Market listing, the liquidity of the Common Stock
would be adversely affected. In addition, Mark's ability to raise additional
working capital through sales of its equity securities would also be adversely
affected.
10. Potential Application of Exchange Act "Penny Stock
Rules. In the event Mark fails to maintain its Nasdaq SmallCap Market listing,
Mark's Common Stock would most likely be a "penny stock" as that term is defined
in the Exchange Act. Brokers effecting transactions in a "penny stock" are
subject to additional customer disclosure and record keeping obligations
including disclosure of the risks associated with low price stocks, stock quote
information and broker compensation. In addition, brokers effecting transactions
in a "penny stock" are also subject to addition sales practice requirements
under Rule 15g-9 of the Exchange Act including making inquiries into the
suitability of "penny stock" investments for each customer or obtaining a prior
written agreement for the specific "penny stock" purchase. Because of these
additional obligations, certain brokers will not effect transactions in "penny
stocks", which could have an adverse effect on the liquidity of the security and
make selling it more difficult.
8
<PAGE>
11. Impact of Conversion Price of Debentures and the Share Adjustment on
Trading Prices of Common Stock. Due to the right of the holders to convert the
Debentures into shares of Common Stock at the discounted rate of 75% of the
market price, rises in the trading price of the Common Stock may met resistance
due to the potential sale of the underlying Common Stock which would be acquired
at below the then current trading price. Similarly, the Adjustment Shares could
have a similar effect if the trading price of the Common Stock remains below
$1.30 per share. In June 1998 a holder converted other debentures in the
principal amount of $750,000 provided Mark agree to issue additional shares of
Common Stock to the extent the trading price fell below $1.25 per share during
the period through January 29, 1999. This adjustment provision may similarly
affect the trading price of the Common Stock.
12. Subcontractor Credit Risk. Mark's manufacturing operations are limited
to the steel modular cell for use as one component of correctional institution
projects. Therefore, Mark may not be the prime contractor on a project, but a
subcontractor. Under these circumstances, Mark usually will not have the direct
financial obligation of the government agency or other purchaser, but will be
primarily relying on the prime contractor regarding payment for its products.
This presents a greater credit risk to Mark.
13. Related Party Transactions; Potential Conflicts of Interests. Mark has
been a party to business transactions with certain officers, Directors or their
affiliates. Mark intends to purchase goods and services in the ordinary course
of business from related parties and may determine based upon circumstances at
that time to engage in additional transactions with officers, Directors,
principal shareholders or affiliates. While Mark believes these transactions
have been on terms no less favorable than could be obtained from unaffiliated
parties, such situations present potential conflicts of interest.
14. No Dividends. Mark has never paid a cash dividend on its Common Stock.
Mark does not intend to pay in the foreseeable future, cash dividends on the
Common Stock but intends to retain its earnings to finance growth.
9
<PAGE>
DESCRIPTION OF SECURITIES
In June 1998, Mark completed a $2,750,000 private placement of equity and debt
units (the "Private Placement") pursuant to which Mark issued the Securities.
The following is a summary of the terms of the Securities.
Private Placement Common Stock and Adjustment Shares. The Private Placement
Common Stock consists of 1,220,000 shares of Common Stock. Holders of the
Private Placement Common Stock are entitled to Adjustment Shares to the extent
the average net proceeds (including commissions) from the sale of any Private
Placement Common Stock during the 180-day period after the date of this
Prospectus is less than an average of $1.30 per share. The number of Adjustment
Shares will be calculated using the closing bid price of the Common Stock on
four trading dates one week apart after Mark receives notice from the holder of
the Private Placement Common Stock.
Accordingly the number of Adjustment Shares is indeterminable.
Debentures. The Debentures consists of $1,530,000 principal amount, have a
maturity date of December 28, 1999 and an interest rate of 7% per annum. The
Debentures are convertible, in part or in whole, into Common Stock at the lesser
of (i) $1.50 per share or (ii) 75% of the average closing bid price of the
Common Stock for the five trading days immediately preceding the conversion
date(s). The interest on the Debentures is payable in cash or Common Stock, at
the option of Mark.
The holders of the Debentures also received an option to purchase additional
debt units, which in the aggregate would consist of (i) $2,550,000 in 18-month
principal amount convertible debentures with terms identical to the Debentures
and (ii) 1,250,000 four-year warrants, each to purchase one share of Common
Stock at $1.50 per share (the "Debenture Option").
Warrants. The Warrants consist of 1,375,000 warrants each to purchase one
share of Common Stock for $1.50 per share expiring on June 28, 2002.
Anti-dilution Provisions. The Securities contain anti-dilution provisions
in the event of stock dividends, stock splits, reverse stock splits and similar
transactions.
10
<PAGE>
Restriction on Acquiring in Excess of Five (5%) of the Outstanding Common Stock.
Each of the Securities includes a provision prohibiting any holder from
acquiring the beneficial ownership of over five (5%) percent of Mark's Common
Stock through the (i) conversion of Debentures, (ii) issuance of Adjustment
Shares, (iii) exercise of the Warrants or (iv) exercise of the Debenture Option.
Issuances over Twenty (20%) Percent of the Outstanding Common Stock Pursuant to
Private Placement. In order to satisfy applicable Nasdaq corporate governance
requirements, Mark is prohibited from issuing in excess of 3,615,334 shares of
Common Stock under the Private Placement until it obtains shareholder approval.
Mark intends to present the matter to its shareholders at its next annual
meeting presently scheduled for November 30, 1998. In the event Mark does not
obtain shareholder approval, (i) the holders of the Private Placement Common
Stock will have the right to demand cash payment equal to the value of the
Adjustment Shares that would have been issuable and (ii) the holders of the
Debentures will have the right to demand Mark redeems the Debentures at 125% of
the principal amount plus accrued interest.
SELLING SHAREHOLDERS
The up to 10,000,000 shares of Common Stock offered hereby are being
offered for the account of the following person(s). The information regarding
such person(s) and beneficial ownership of Common Stock has been provided by the
Selling Shareholders.
<TABLE>
<CAPTION>
Shares of Shares of Total Shares Shares of
Shares of Common Common of Common Common
Private Stock Stock Stock Stock
Placement Issuable Issuable Benefically Owned
Common Under Under Owned and After
Name Stock(1) Debentures(2) Warrants Offered(1)(2) Offering(1)(2)
- ---------------------------- -------- ------------- -------- ------------- -------------
<S> <C> <C> <C> <C> <C>
Jules Nordlicht ............ 320,000 853,333 400,000 1,893,333 0
Huberfeld Bodner
Family Foundation ....... 300,000 800,000 375,000 1,475,000 0
Mark Nordlicht ............. 80,000 213,333 100,000 393,333 0
John Georgalis ............. 200,000 0 100,000 300,000 0
Harry Adler ................ 40,000 106,667 50,000 196,667 0
Rita Folger ................ 40,000 106,667 50,000 196,667 0
Mechon L'Hoyroa ............ 22,500 60,000 28,125 110,625 0
Joseph Antine .............. 20,000 53,333 35,000 108,333 0
Philip Huberfeld ........... 20,000 53,333 35,000 108,333 0
Issac Levy ................. 20,000 53,333 35,000 108,333 0
Beth Medrash Gevoa of Israel 20,000 53,333 35,000 108,333 0
Abraham Elias .............. 20,000 53,333 35,000 108,333 0
</TABLE>
11
<PAGE>
<TABLE>
<CAPTION>
Shares of Shares of Total Shares Shares of
Shares of Common Common of Common Common
Private Stock Stock Stock Stock
Placement Issuable Issuable Benefically Owned
Common Under Under Owned and After
Name Stock(1) Debentures(2) Warrants Offered(1)(2) Offering(1)(2)
- ---------------------------- -------- ------------- -------- ------------- -------------
<S> <C> <C> <C> <C> <C>
Congregation of Ahavas Tzdodak
V'Chesed ................. 20,000 53,333 35,000 108,333 0
Abraham Ziskind ............ 20,000 53,333 35,000 108,333 0
Jerusalem Fund ............. 20,000 53,333 35,000 108,333 0
Shor Yoshuv Institute ...... 20,000 53,333 35,000 108,333 0
Josh Berkowitz ............. 10,000 26,667 17,500 54,167 0
Yeshiva of Telshe Alumni ... 10,000 26,667 17,500 54,167 0
Shekel HaKodesh ............ 5,000 13,334 8,750 27,084 0
Judah Perstein ............. 5,000 13,334 8,750 27,084 0
Ahron Schiller ............. 2,500 6,667 4,375 13,542 0
Rebecca Adika .............. 2,500 6,667 4,375 13,542 0
Elissa Eisner .............. 2,500 6,667 4,375 13,542 0
<FN>
(1) Excludes potential Adjustment Shares.
(2) Assumes interest paid in cash. Based on a conversion rate of 75% of the
closing sale price of $.75 on August 24, 1998 </FN>
</TABLE>
PLAN OF DISTRIBUTION
The sale of shares of Common Stock by the Selling Shareholders may be
effected from time to time in transactions on one or more exchanges or in the
over-the-counter market, or otherwise in negotiated transactions, through the
timing of options on the shares or through a combination of such methods of
sale, at fixed prices, which may be charged at market prices prevailing at the
time of sale, at prices related to such prevailing market prices or at
negotiated prices. The Selling Shareholders may effect such transactions by
selling the shares of Common Stock in an exchange distribution in accordance
with the rules of such exchange to or through broker-dealers, and such
broker-dealers may receive compensation in the form of discounts, concessions or
commissions from the Selling Shareholders and/or the purchasers of the shares of
Common Stock for which such broker-dealer may act as agent or to whom they sell
as principal, or both (which compensation as to a particular broker-dealer may
be in excess of customary compensation). The Selling Shareholders and any
broker-dealers who act in connection with the sale of the shares of Common Stock
hereunder may be deemed to be "underwriters" within the meaning of Section 2(11)
of the Securities Act, and any commissions received by them and profit on any
sale of the shares of Common Stock as principal might be deemed to be
underwriting discounts and commissions under the Securities Act.
12
<PAGE>
In addition any securities covered by the Prospectus which qualify for sale
pursuant to Rule 144 may be sold under Rule 144 rather than pursuant to the
Prospectus, as supplemented. From time to time the Selling Shareholders may
engage in short sales, short sales against the box, puts and calls and other
transactions in securities of Mark or derivatives thereof, and may sell and
deliver the shares in connection therewith.
From time to time Selling Shareholders may pledge their shares pursuant to
the margin provisions of their respective customer agreements with their
respective brokers. Upon a default by a Selling Shareholder, the broker may
offer and sell the pledged shares of the Common Stock from time to time.
LEGAL MATTERS
Timothy J. McCartney, Esq. has acted as counsel for Mark and has rendered
an opinion on the validity of the shares of Common Stock to be issued pursuant
to the Securities.
EXPERTS
Mark's consolidated balance sheets as of June 30, 1997 and 1996 and the
consolidated statements of operations, stockholders' equity and cash flows for
each of the three years in the period ended June 30, 1997 incorporated by
reference in this Prospectus, have been incorporated herein in reliance on the
report of Sax Macy Fromm & Co., P.C., independent certified public accountants,
given on the authority of that firm as experts in accounting and auditing.
13
<PAGE>
PART II
INFORMATION NOT REQUIRED IN FORM S-3 PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
The following is a list of the estimated expenses to be incurred by the
Registrant in connection with the issuance and distribution of the securities
being registered hereby, other than underwriting discounts and commissions.
Item Amount
Registration Fee . . . . . . . . . . . . . . . . . $ 2,273
Accountants' Fees and Expenses . . . . . . . . . . . 3,000
Blue Sky Filing Fees and Expenses . . . . . . . . . 3,000
Legal Fees and Expenses . . . . . . . . . . . . . . 10,000
Miscellaneous . . . . . . . . . . . . . . . . . . . 4,000
--------
Total . . . . . . . . . . . . . . . . . . . $ 22,273
========
Item 15. Indemnification of Directors and Officers.
Reference is made to Article Seven of the Certificate of Incorporation
of the Registrant and Section 145 of the Delaware General Corporation Law.
Article Seventh of the Certificate of Incorporation of the Registrant
provides for indemnification to the full extent permitted by Delaware law of all
persons whom it shall have the power to indemnify thereunder. Section 145 of the
General Corporation Law of the State of Delaware ("GCL") contains provisions
entitling directors and officers of the Registrant to indemnification from
judgments, fines, amounts paid in settlement and reasonable expenses, including
attorney's fees, as the result of being or having been a director or officer of
the Registrant provided said officers or directors acted in good faith. GCL
Section 145 provides broad powers of indemnification of directors and officers
by their corporation. For example, the board of directors, the shareholders, or
independent legal counsel in some circumstances may authorize the corporation to
indemnify any officer or director again expenses (including attorneys' fees),
judgments, fines and amounts paid in settlement, actually and reasonable
incurred by him in connection with any "threatened, pending or completed action,
suit or proceeding other than an action by or in the right of the corporation,
whether civil, criminal, administrative or investigative - by reason of the fact
that he is or was a director or officer of the corporation, if such director or
officer acted in good faith and in a manner he reasonably believed to be in or
not opposed to the best interests
II-1
<PAGE>
of the corporation, and, with respect to any criminal action or proceeding, had
no reasonable cause to believe his conduct was unlawful". With respect to any
threatened, pending or completed action or suit by or in the right of a Delaware
corporation, the corporation may in like manner indemnify any officer or
director against expenses (including attorneys' fees) actually and reasonably
incurred by him in connection with the defense or settlement of such action or
suit if he acted in good faith and in a manner he reasonably believed to be in
or not opposed to the best interest of the corporation and except that no
indemnification shall be made in respect of any claim, issue or matter as to
which such personal shall have been adjudged to be liable for negligence or
misconduct in the performance of his duty to the corporation, but only if and to
the extent that the Court of Chancery or the court in which the action or suit
was brought shall determine upon application that, despite the adjudication of
liability but in view of all the circumstances of the case, such person is
fairly and reasonably entitled to indemnity for such expenses which the Court of
Chancery or such other court shall deem proper.
Should a director or officer defend litigation arising out of his office
and be successful on the merits or otherwise in defense of the action, GCL
Section 145 provides that such officer or director shall be indemnified against
expenses (including attorneys' fees) actually and reasonably incurred by him in
connection therewith.
Finally, a corporation organized under the GCL shall have power to purchase
and maintain insurance on behalf of any director or officer against any
liability asserted against him and incurred by him in such capacity or arising
out of his status as an officer or a director, whether or not the corporation
would have the power to indemnify him against such liability under the before
described provisions of Section 145 of the GCL.
Item 16. Exhibits.
The exhibits to this Registration Statement are listed in the
Exhibit Index hereto and are incorporated herein by reference.
Item 17. Undertakings.
(A) Insofar as indemnification for liabilities arising under
the Act may be permitted to directors, officers and controlling persons, if any,
of the Registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that, in the opinion of the Securities and Exchange
Commission, such indemnification is against public policy as expressed in the
Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities
II-2
<PAGE>
(other than the payment by the Registrant of expenses incurred or paid by a
director, officer or controlling person of the Registrant in the successful
defense of any action suit or proceeding) is asserted by any such director,
officer or controlling person in connection with the securities being
registered, the Registrant will, unless, in the opinion of its counsel, the
matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question of whether such indemnification by it is
against public policy as expressed in the Act and will be governed by the final
adjudication of such issue.
(B) With respect to the common stock underlying the Warrants,
the undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration statement;
(i) To include any prospectus required by Section
10 (a) (3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the
registration statement;
(iii) To include any material information with respect
to the plan of distribution not previously disclosed in the registration
statement or any material change to such information in the registration
statement;
(2) That, for the purpose of determining any liability under
the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the
termination of the offering.
(4) The undersigned Registrant hereby undertakes to supply by
means of a post-effective amendment all information concerning a transaction,
and the company being acquired involved therein, that was not the subject of and
included in the registration statement when it became effective.
II-3
<PAGE>
POWER OF ATTORNEY
Mark Solutions, Inc., and each of the undersigned do hereby appoint Carl
Coppola, its or their true and lawful attorney to execute on behalf of Mark
Solutions, Inc. and the undersigned any and all amendments (including
post-effective amendments) to this Registration Statement and to file the same
with all exhibits thereto and other documents in connection therewith, with the
Securities and Exchange Commission.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-3 and that it has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the Town of Bloomfield, State of New Jersey, on August 28,
1998.
MARK SOLUTIONS, INC.
By: /s/ Carl Coppola
-------------------
(Carl Coppola, Chief
Executive Officer and
President)
Pursuant to the requirements of the Securities Act of 1933,
this registration statement has been signed below by the following persons in
the capacities and on the date indicated.
Signature Title Date
/s/ Carl Coppola Chief Executive Officer August 28, 1998
(Carl Coppola) President and Director
(Principal Executive
Officer),
/s/ Michael Nafash Chief Financial Officer, August 28, 1998
(Michael Nafash) Vice President- Finance
and Director (Principal
Financial and Accounting
Officer)
/s/ Richard Branca Director August 28, 1998
(Richard Branca)
/s/ Yitz Grossman Director August 28, 1998
(Yitz Grossman)
/s/ Ronald E. Olszowy Director August 28, 1998
(Ronald E. Olszowy)
/s/ William Westerhoff Director August 28, 1998
(William Westerhoff)
II-4
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description
2. a) -- Stock Purchase Agreement between Mark
and Ian Baverstock, Jonathan Newth,
David Payne and Joanna Tubbs dated
April 5, 1996. (Incorporated by
reference to Exhibit 1 to Mark's
Current Report on Form 8-K - Date
Of Report May 28, 1996, referred to
herein as "Mark's Form 8-K").
b) -- Stock Purchase Agreement between Mark
and Christopher Cummins and Moira Addington
dated April 24, 1996. (Incorporated by
reference to Exhibit 2 to Mark's Form 8-K).
3. a) -- Certificate of Incorporation, as amended
(Incorporated by reference to Exhibit 3.a)
to Mark's Form 10-K for the fiscal
year ended June 30, 1994)
b) -- By-laws ((Incorporated by reference
to Exhibit 3 b) to Mark's Proxy
Statement/Prospectus, under its former name
"Showcase Cosmetics, Inc.", dated October 8, 1993
to Form S-4 Registration Statement [File No. 33-61176],
referred to herein as "Mark's Form S-4").
4. a) -- Specimen Stock Certificate
(Incorporated by reference to Mark
Exhibit 4 a) to Mark's Form S-4)
5. Opinion of Timothy J. McCartney, Esq.
23. a) -- Consent of Sax Macy Fromm & Co., P.C.
(included on page II-7)
II-5
<PAGE>
Exhibit
Number Description
23 b) -- Consent of Timothy J. McCartney,
Esq. (included in Exhibit 5)
24. Power of Attorney (included on page
II-4)
II-6
<PAGE>
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
We consent to the incorporation by reference in this Registration Statement
on Form S-3 of our report dated August 22, 1997 (except for Note 1, as to which
date is September 23, 1997), on our audits of the consolidated financial
statements of Mark Solutions, Inc.'s ("Mark") as of June 30, 1997 and 1996 and
for the years ended June 30, 1997, 1996 and 1995 appearing in Mark's Annual
Report on Form 10-K for the year ended June 30, 1997. We also consent to the
reference to us under the heading "Experts" in the Prospectus which is part of
the Registration Statement.
Sax Macy Fromm & Co., P.C.
Certified Public Accountants
Clifton, New Jersey
August 28, 1998
II-7
<PAGE>
TIMOTHY J. McCARTNEY*
Attorney-at-Law
9 Elsa Way
Richboro, Pennsylvania 18954
------
Telephone (215) 396-7156
Facsimile (215) 396-7157
* Member of N.Y. Bar
August 28, 1998
Mark Solutions, Inc.
1551 Broad Street
Bloomfield, New Jersey 07003
Gentlemen:
I have acted as counsel to Mark Solutions, Inc. ("Mark") in connection with the
registration on Form S-3 (the "Registration Statement") by Mark under the
Securities Act of 1933, as amended (the "Securities Act") of 10,000,000 shares
of Mark Common Stock, $.01 par value (the "Shares") and the related prospectus.
On the basis of such investigation as I have deemed necessary, I am of the
opinion that:
1. The 1,220,000 Shares referred to as the Private Placement Common Stock has
been duly authorized, validly issued, fully paid and nonassessable.
2. The 1,375,000 Shares underlying the Warrants have been duly authorized
and reserved for issuance by Mark and when issued by Mark in accordance
with the terms of the Warrants, will be duly authorized, validly issued,
fully paid and nonassessable.
3. The Adjustment Shares and the Shares issuable under the Debentures have
been duly authorized and reserved for issuance by Mark and when issued
by Mark in accordance with the applicable terms, will be duly
authorized, validly issued, fully paid and nonassessable.
I hereby consent to the filing of this opinion as an exhibit to the Registration
Statement and to the reference to my name under the caption "Legal Matters" set
forth in the prospectus.
Very Truly Yours,
Timothy J. McCartney
